Anwei Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Anwei Chen has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Tao Wang
Department of Oral and Maxillofacial Surgery, Qilu Hospital of Shandong University, Jinan, China
2 shared publicationsC. Yang
Department of Oral and Maxillofacial Surgery, Qilu Hospital, Institute of Stomatology, Shandong University, Jinan, Shandong Province, PR China
1 shared publication- Jie Xu
School of Stomatology, Shandong University, No. 44, Wenhuaxi-Road, Jinan, 250012 People's Republic of China ; Department of Oral and Maxillofacial Surgery, Stomatology Hospital of Jinan, No. 101, Jingliu-Road, Jinan, 250012 People's Republic of China
1 shared publication Liu Shaohua
Department of Oral and Maxillofacial Surgery, Qilu Hospital, Shandong University, Jinan, Shandong, China
1 shared publicationS. Liu
Department of Oral and Maxillofacial Surgery, Qilu Hospital, Institute of Stomatology, Shandong University, Jinan, Shandong Province, PR China
1 shared publicationShaohua Liu
Department of Oral and Maxillofacial Surgery, Qilu Hospital of Shandong University, Jinan, China
1 shared publication
Latest Publications
- 20 August 2026
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 52 (10) , e121-e125
Effect of Mesh on Foam Stability in Foam Preparation for Sclerotherapy
BACKGROUND: Foam sclerotherapy is effective for venous malformations, but the stability of physician-compounded foam is crucial. The effect of mesh pore size on stability remains unclear. OBJECTIVE: To investigate how varying mesh pore sizes affect foam stability and bubble morphology. MATERIALS AND METHODS: Foam was prepared using a double syringe system with 1% Polidocanol (1:4 ratio). Six groups were tested: 1 control (no mesh) and 5 experimental groups with meshes (40–160 mesh). Foam half-life time (FHT) and bubble diameter were measured. RESULTS: Meshes significantly increased FHT compared with the control ( p < .001). A smaller pore size correlated with longer FHT (up to 299 s) and smaller, more uniform bubbles (reduction of 44.95%–65.84% in diameter). CONCLUSION: Integrating a mesh into the double syringe system enhances foam stability. Smaller pore sizes produce finer, more stable foam, suggesting 40 to 160 mesh as the optimal clinical range.
- 20 August 2026
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 52 (10) , e121-e125
Effect of Mesh on Foam Stability in Foam Preparation for Sclerotherapy
BACKGROUND: Foam sclerotherapy is effective for venous malformations, but the stability of physician-compounded foam is crucial. The effect of mesh pore size on stability remains unclear. OBJECTIVE: To investigate how varying mesh pore sizes affect foam stability and bubble morphology. MATERIALS AND METHODS: Foam was prepared using a double syringe system with 1% Polidocanol (1:4 ratio). Six groups were tested: 1 control (no mesh) and 5 experimental groups with meshes (40–160 mesh). Foam half-life time (FHT) and bubble diameter were measured. RESULTS: Meshes significantly increased FHT compared with the control ( p < .001). A smaller pore size correlated with longer FHT (up to 299 s) and smaller, more uniform bubbles (reduction of 44.95%–65.84% in diameter). CONCLUSION: Integrating a mesh into the double syringe system enhances foam stability. Smaller pore sizes produce finer, more stable foam, suggesting 40 to 160 mesh as the optimal clinical range.
- 1 July 2021
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 50 (7) , 980
Preliminary experience with promethazine hydrochloride injection in the sclerotherapy of oral mucocele
- 1 July 2021
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 50 (7) , 980
Preliminary experience with promethazine hydrochloride injection in the sclerotherapy of oral mucocele
- 1 April 2021
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 50 (4) , 516-521
Preliminary experience with promethazine hydrochloride injection in the sclerotherapy of oral mucocele
- 1 April 2021
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 50 (4) , 516-521
Preliminary experience with promethazine hydrochloride injection in the sclerotherapy of oral mucocele
- 5 August 2020
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 46 (12) , 1712-1714
A Novel Compound Sclerosant: Polidocanol–Bleomycin Foam
BACKGROUND: Foam sclerotherapy is an effective treatment strategy for venous malformations. Both polidocanol (POL) and bleomycin are effective sclerosants; however, no studies have reported POL–bleomycin foam. OBJECTIVE: To introduce a method for producing POL–bleomycin foam and evaluate the stability of POL–bleomycin foam with bleomycin concentrations. MATERIALS AND METHODS: Group A: 2 mL of 1% POL + 8 mL of air; Group B: 2 mL of 1% POL + 3 U bleomycin + 8 mL of air; Group C: 2 mL of 1% POL + 6 U bleomycin + 8 mL of air; Group D: 2 mL of 1% POL + 12 U bleomycin + 8 mL of air. Tessari method was used for foam generation. The foam half-life time (FHT) was used to evaluate foam stability. Five recordings were made for each group. RESULTS: The FHT was 148.6 ± 2.9 seconds in Group A, 148.8 ± 4.0 seconds in Group B, 148.4 ± 2.6 seconds in Group C, and 148.8 ± 1.6 seconds in Group D. The FHT in different groups showed no significant differences. CONCLUSION: The POL–bleomycin foam was prepared successfully and its FHT was as long as the POL foam.
- 5 August 2020
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 46 (12) , 1712-1714
A Novel Compound Sclerosant: Polidocanol–Bleomycin Foam
BACKGROUND: Foam sclerotherapy is an effective treatment strategy for venous malformations. Both polidocanol (POL) and bleomycin are effective sclerosants; however, no studies have reported POL–bleomycin foam. OBJECTIVE: To introduce a method for producing POL–bleomycin foam and evaluate the stability of POL–bleomycin foam with bleomycin concentrations. MATERIALS AND METHODS: Group A: 2 mL of 1% POL + 8 mL of air; Group B: 2 mL of 1% POL + 3 U bleomycin + 8 mL of air; Group C: 2 mL of 1% POL + 6 U bleomycin + 8 mL of air; Group D: 2 mL of 1% POL + 12 U bleomycin + 8 mL of air. Tessari method was used for foam generation. The foam half-life time (FHT) was used to evaluate foam stability. Five recordings were made for each group. RESULTS: The FHT was 148.6 ± 2.9 seconds in Group A, 148.8 ± 4.0 seconds in Group B, 148.4 ± 2.6 seconds in Group C, and 148.8 ± 1.6 seconds in Group D. The FHT in different groups showed no significant differences. CONCLUSION: The POL–bleomycin foam was prepared successfully and its FHT was as long as the POL foam.
- Open Access
- 19 February 2016
- Published by Springer Nature in SpringerPlus
- Vol. 5 (1) , 1-3
A modified Tessari method for producing more foam
This study aimed to develop a modified Tessari method for producing more sclerosing foam in treatment of extensive venous malformations. Sclerosing foam was produced by using Tessari method and the modified Tessari method. The procedure of the later was as follows: prepared foam in a sclerosant–air ratio of 1:4; connected three disposable 10 ml syringes to two medical three-way taps; drawn 4 ml of liquid sclerosant into one syringe and 16 ml averagely of air into the other two; then moved the plungers of all syringes back and forth for 20 times to produce sclerosing foam. The volume and foam half time (FHT) of foam produced by the two methods were compared. The average volume of sclerosing foam produced by Tessari method and the modified Tessari method were 9.8 and 19.7 ml, and assessed to have statistical difference. The FHT of foam produced by the two methods were 120 and 150 s, and assessed to have statistical difference. In conclusion, the modified Tessari method could produce more fresh and stable sclerosing foam.
- 19 February 2016
- Published by Springer Nature in SpringerPlus
- Vol. 5 (1) , 1-3
Open AccessA modified Tessari method for producing more foam
This study aimed to develop a modified Tessari method for producing more sclerosing foam in treatment of extensive venous malformations. Sclerosing foam was produced by using Tessari method and the modified Tessari method. The procedure of the later was as follows: prepared foam in a sclerosant–air ratio of 1:4; connected three disposable 10 ml syringes to two medical three-way taps; drawn 4 ml of liquid sclerosant into one syringe and 16 ml averagely of air into the other two; then moved the plungers of all syringes back and forth for 20 times to produce sclerosing foam. The volume and foam half time (FHT) of foam produced by the two methods were compared. The average volume of sclerosing foam produced by Tessari method and the modified Tessari method were 9.8 and 19.7 ml, and assessed to have statistical difference. The FHT of foam produced by the two methods were 120 and 150 s, and assessed to have statistical difference. In conclusion, the modified Tessari method could produce more fresh and stable sclerosing foam.